辉瑞制药（Pfizer）2021年年度报告（英文版）

Annual ReviewBreakthroughs thatchange patients’ livesPfizer 2021Pfizer 2021 Annual Review2ContentsA Year In ReviewA Letter From Our Chairman & CEO2021 In NumbersOur PeopleBold Moves2021 StoriesInternal MedicineInflammation & ImmunologyOncologyRare DiseaseVaccinesCommercialPfizer Global SupplyResearch & DevelopmentCOVID-19OtherESGA Closer LookProgress and HighlightsPerformanceFinancial PerformanceAbout This ReviewCorporate Shareholder Information0304070911121314152122262830314147484951525455Pfizer 2021 Annual Review3A Year In ReviewBringing scientific breakthroughs to patients around the world.In 2021, we broke new ground for patients with regulatory approvals for new medicines or indications, the delivery of our life-saving COVID-19 vaccine to populations around the world, and the introduction of a potentially game-changing oral treatment for COVID-19.A Year In ReviewPfizer 2021 Annual Review4Letter from Our Chairman & CEOTo Our Shareholders 2021 was a watershed year for Pfizer. A year